Tumor cells from a mouse T-ALL model generated by the T-cell specific deletion of PTEN display a constitutive activation of PI3K/Akt/mTOR that could be inhibited by metformin through AMPK activation and by torkinibs (80). This evidence concerns the gene PRKAA1 and acute lymphoblastic leukemia.